AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...

Two software companies that track documents and data for clinical trials have forged a partnership to cut the amount of time it takes life science firms to submit applications for approval from the ...

Medable is taking its digital clinical trial platform to new heights: the Google Cloud Marketplace. Through the collaboration, Google Cloud’s infrastructure and AI features will be integrated into ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent architecture for clinical research. We believe the future of clinical research ...

Morning Hubsters, John R Fischer here in the New York newsroom coming at you with the US Wire. Surgical procedures are on the rise – several sources estimate over 300 million are performed each year ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Leading clinical trial software solutions innovator Greenphire has just released its annual Market Trends survey sharing invaluable insights from nearly 400 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The largest medical device maker ...

Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...

Patient-facing clinical trial software company uMotif has raised $3.2 million (£2.4 million) in a new funding round led by independent investment manager Albion Capital, with additional participation ...

Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies ...